Bioptic

Bioptic Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Bioptic (6850.TWO) as of Nov 11, 2026 is 732.00. In the previous year, Days Inventory Outstanding (DIO) was 778.44 — a change of -5.97% (lower).

Days Inventory Outstanding

732.00

YoY

-5.97%

Last updated:

Days Inventory Outstanding (DIO) of Bioptic is 2024 732.00 . Days Inventory Outstanding (DIO) of Bioptic was 2023 778.44 . It decreases by -5.97% lower compared to the previous year.

The Bioptic Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2020
369.42 TWD
Jan 1, 2021
409.54 TWD
Jan 1, 2022
555.92 TWD
Jan 1, 2023
778.44 TWD
Jan 1, 2024
732.00 TWD
The Bioptic Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
732.00-5.97%
778.44+40.03%
555.92+35.74%
409.54+10.86%
369.42—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioptic Stock analysis

What does Bioptic do? BiOptic Inc generates revenue through the sale of capillary electrophoresis instruments, including the Qsep100, Qsep1, and Qsep400 series, which are used for biomolecule separation and detection. The company also sells related consumables such as S1, S2, S3, F3 cassettes for DNA fragment analysis, R1 and NR1 cassettes for RNA detection, P2 cassettes for protein analysis, and Q series for quantitative detection. Additionally, BiOptic Inc offers reagents including polymerase chain reaction reagents, veterinary medicine-related reagents, human gene detection reagents, and food-related reagents. These products are primarily sold to customers in China, Hong Kong, and Taiwan, with the company focusing on the healthcare and research sectors. The firm's main customer segments include laboratories, hospitals, and research institutions that require advanced detection equipment and consumables for genetic and molecular analysis. BiOptic Inc's product portfolio targets both human and veterinary medical applications, as well as food safety testing, indicating a diversified market approach. The company's focus on high-precision instruments and specialized reagents positions it to serve clients needing reliable solutions for nucleic acid and protein analysis. BiOptic Inc's revenue streams are derived from direct sales of its instruments, cassettes, and reagents to end-users in the healthcare and research sectors. The company's products are designed for specific applications, such as DNA, RNA, and protein detection, which drives demand from specialized laboratories and medical facilities. By offering a comprehensive range of products, BiOptic Inc ensures that its customers can access all necessary tools for their molecular analysis needs within a single supplier. Bioptic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioptic stock

Days Inventory Outstanding (DIO) of Bioptic is 732.00 in 2024.

Days Inventory Outstanding (DIO) of Bioptic changed from 778.44 to 732.00, representing a -5.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Bioptic since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Bioptic with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Bioptic

All Key Metrics — Bioptic